Larry Hayward
Impact in
-
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 17
- Cancer Treatment and Pharmacology 7
- Vascular Tumors and Angiosarcomas 4
- HER2/EGFR in Cancer Research 3
-
- Epigenetics and DNA Methylation 4
- Histone Deacetylase Inhibitors Research 3
- Co-authors
- Jayne Culley (2 shared papers)C. Logan Mackay (2 shared papers)Pat R. R. Langridge‐Smith (2 shared papers)David J. Harrison (2 shared papers)Bernard Ramsahoye (2 shared papers)Tom Latham (1 shared paper)Duncan Sproul (1 shared paper)Nick Gilbert (1 shared paper)
- Journals
- Journal of Clinical Oncology (6 papers)Annals of Oncology (3 papers)Cancer Research (3 papers)Molecular Oncology (1 paper)Biochemical Society Transactions (1 paper)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Larry Hayward
28 papers receiving 680 citations
Peers
Comparison fields: 5 of 92
- Cancer Research 124
- Oncology 168
- Molecular Biology 350
- Cell Biology 81
- Immunology 90
Countries citing papers authored by Larry Hayward
This map shows the geographic impact of Larry Hayward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry Hayward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry Hayward more than expected).
Fields of papers citing papers by Larry Hayward
This network shows the impact of papers produced by Larry Hayward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry Hayward. The network helps show where Larry Hayward may publish in the future.
Co-authors
The 25 scholars most cited alongside Larry Hayward, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 266 | |
| 2 | 2004 | 102 | |
| 3 | 2012 | 42 | |
| 4 | 2014 | 41 | |
| 5 | 2017 | 41 | |
| 6 | 2011 | 40 | |
| 7 | 2017 | 31 | |
| 8 | 2012 | 21 | |
| 9 | 2014 | 16 | |
| 10 | 2019 | 15 | |
| 11 | 2008 | 11 | |
| 12 | 2014 | 10 | |
| 13 | 1986 | 10 | |
| 14 | 2013 | 7 | |
| 15 | 2017 | 6 | |
| 16 | 2021 | 4 | |
| 17 | 2022 | 4 | |
| 18 | 2023 | 3 | |
| 19 | 2016 | 3 | |
| 20 | 2012 | 2 |
About Larry Hayward
Larry Hayward is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 31 papers that have together received 684 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (7 papers), Breast Cancer Treatment Studies (6 papers), Sarcoma Diagnosis and Treatment (5 papers), Vascular Tumors and Angiosarcomas (4 papers), Epigenetics and DNA Methylation (4 papers), HER2/EGFR in Cancer Research (3 papers), Histone Deacetylase Inhibitors Research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Cancer Research (124 citations), Oncology (168 citations), Molecular Biology (350 citations), Cell Biology (81 citations) and Immunology (90 citations). Larry Hayward has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Jayne Culley, C. Logan Mackay, Pat R. R. Langridge‐Smith, David J. Harrison, Bernard Ramsahoye, Tom Latham, Duncan Sproul, Nick Gilbert, Linghua Meng and Yves Pommier. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Molecular Oncology and Biochemical Society Transactions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.